Sign in / Join Now
ETFs & Funds
Alex B. Gray
& Daiichi Sankyo Co. expand their research, development and license agreement for the discovery of novel kinase inhibitors.
Add a reply...
Latest StockTalks »
people get ARQL breaking news and analysis by email alert.
Get email alerts on ARQL »
Get latest price
From other sites
ArQule (ARQL) Shows Strength: Stock Adds 8% in Session
at Zacks.com (Jun 23, 2016)
ArQule (ARQL) Shows Strength: Stock Adds 7.6% in Session
at Zacks.com (Feb 19, 2016)
ArQule's Drug Gets Orphan Drug Status for Proteus Syndrome
at Zacks.com (Nov 18, 2015)
ArQule Reports Interim Data from Colorectal Cancer Study - Analyst Blog
at Zacks.com (Jul 7, 2015)
Can The Uptrend Continue for ArQule (ARQL)? - Tale of the Tape
at Zacks.com (Mar 12, 2015)